Bioventus announces new president, CEO
Click Here to Manage Email Alerts
Key takeaways:
- Bioventus announced Robert Claypoole as its incoming president and CEO, effective Jan. 10, 2024.
- Claypoole most recently served as executive vice president of Mölnlycke Health Care AB.
Bioventus Inc. has announced Robert Claypoole as its incoming president and CEO, effective Jan. 10, 2024, according to a press release.
Claypoole, who was also elected as a member of the board of directors, will succeed Anthony Bihl, who served as interim CEO and director of the board since April of 2023.
Claypoole has more than 20 years of leadership experience in the medical device industry. He most recently served as executive vice president of Mölnlycke Health Care AB and has held senior positions at Medtronic, Covidien and Johnson & Johnson.
“I am honored to join the talented team at Bioventus, a company with a strong foundation and a diverse, market-leading product portfolio across attractive markets,” Claypoole said in the release. “I was attracted to this unique and exciting opportunity given our important mission to return patients to active lives and due to the company’s positive momentum this year to solidify Bioventus’ financial position. I look forward to working with the board and entire team to drive growth and innovation, generate operational efficiencies and strengthen profitability as we unlock the full potential of our business and create value for patients and our shareholders,” he added.
Read more about
Click Here to Manage Email Alerts